HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew Huska Selected Research

Hepatitis D

1/2022SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew Huska Research Topics

Disease

1COVID-19
01/2022
1Hepatitis D
01/2022
1Infections
01/2022

Drug/Important Bio-Agent (IBA)

1N-(2-cyanoethylene)urea (BA 1)IBA
01/2022
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2022